Directly hitting the afternoon of the first day of the 2025 National Conference: Pfizer, Qilu, and many other Chinese and foreign companies enter the venue

The negotiation for the national medical insurance catalog in 2025 officially started today. Journalists on site learned that around 1:30 PM, the participating companies included Boehringer Ingelheim, Pfizer, Qilu Pharmaceutical, Kangyuan Pharmaceutical, Baile Pharmaceutical, Shengdi Pharmaceutical, Fosun Pharma, and Fresenius Kabi, among others. Earlier in the morning, the participating companies included LIVZON PHARMA, Innovent Biologics, Roche, and AstraZeneca